Avenue therapeutics reports third quarter 2022 financial results and recent corporate highlights

New york, nov. 10, 2022 (globe newswire) -- avenue therapeutics, inc. (nasdaq: atxi) (“avenue” or the “company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of central nervous system diseases (“cns”), today reported financial results and recent corporate highlights for the third quarter ended september 30, 2022.
ATXI Ratings Summary
ATXI Quant Ranking